(0.25%) 5 144.25 points
(0.23%) 38 530 points
(0.34%) 17 907 points
(-0.44%) $83.48
(1.98%) $1.961
(0.00%) $2 347.30
(0.30%) $27.62
(0.81%) $929.55
(-0.20%) $0.933
(-0.30%) $10.99
(-0.29%) $0.798
(1.14%) $92.92
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 9.40%
@ $29.13
发出时间: 14 Feb 2024 @ 03:52
回报率: -9.62%
上一信号: Feb 13 - 23:58
上一信号:
回报率: -1.81 %
Live Chart Being Loaded With Signals
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States...
Stats | |
---|---|
今日成交量 | 287 074 |
平均成交量 | 501 528 |
市值 | 1.22B |
EPS | $0 ( 2024-02-29 ) |
下一个收益日期 | ( $0.650 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 29.58 |
ATR14 | $0.0190 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Pace Gary W | Sell | 1 066 | Common Stock |
2024-03-07 | Pace Gary W | Sell | 28 257 | Common Stock |
2024-03-08 | Pace Gary W | Sell | 90 000 | Common Stock |
2024-02-05 | Williams Kristen | Buy | 33 700 | Common Stock |
2024-02-05 | Gaugler Daryl | Buy | 33 700 | Common Stock |
INSIDER POWER |
---|
58.65 |
Last 95 transactions |
Buy: 1 581 500 | Sell: 429 616 |
音量 相关性
Pacira Biosciences Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Pacira Biosciences Inc 相关性 - 货币/商品
Pacira Biosciences Inc 财务报表
Annual | 2023 |
营收: | $674.98M |
毛利润: | $433.02M (64.15 %) |
EPS: | $0.910 |
FY | 2023 |
营收: | $674.98M |
毛利润: | $433.02M (64.15 %) |
EPS: | $0.910 |
FY | 2022 |
营收: | $666.82M |
毛利润: | $467.53M (70.11 %) |
EPS: | $0.350 |
FY | 2021 |
营收: | $541.53M |
毛利润: | $401.28M (74.10 %) |
EPS: | $0.944 |
Financial Reports:
No articles found.
Pacira Biosciences Inc
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。